Introduction
Abnormal cellular Ca 2þ handling and excitation-contraction coupling contribute to reduced contractile function and arrhythmogenesis in heart failure (HF). 1 Ca 2þ uptake into the sarcoplasmic reticulum (SR) by SERCA, Ca 2þ release through ryanodine receptors (RyRs), Ca 2þ extrusion across the sarcolemma by the Na þ /Ca 2þ exchanger (NCX), and Ca 2þ influx via L-type Ca 2þ channels (LTCCs) all contribute to this process. Novel Ca 2þ pathways also emerge such as flux through TRP channels. 2 Functional changes in Ca 2þ handling occur through alteration in protein expression or through post-translational modifications. Signalling pathways involved in remodelling of Ca 2þ handling include those mediated by reactive oxygen species (ROS), Ca 2þ /calmodulin-dependent kinase II (CaMKII), and nitric oxide (NO). Loss of SR Ca 2þ through 'leaky'
RyRs is attributed to post-translational modifications of RyRs that lead to alterations in RyR Ca 2þ sensitivity and open probability (P o ). In animal models of disease, increased SR Ca 2þ leak is observed after myocardial infarction (MI) compared with control 3 as well as in HF, 4 diabetes, 5 and atrial fibrillation (AF). 6 In human myocytes, greater Ca 2þ leak was reported in HF 7 and AF 8, 9 although one study found that spontaneous release events, Ca 2þ sparks, were less frequent in HF. 10 Ca 2þ loss through RyRs reduces contraction by decreasing the SR Ca 2þ content, and can be a trigger to induce arrhythmogenic Ca 2þ waves through activation of NCX. Changes in the subcellular architecture of cardiac myocytes with disease further modulate Ca 2þ handling. Reduced density and disorganization of the transverse and axial tubular system (TATS) is seen in post-MI remodelling. [11] [12] [13] These and other data suggest that TATS remodelling is a general feature in the progression to HF. 14 In contrast, RyR clusters appear to remain distributed at the Z lines throughout the cell, resulting in a large fraction of RyRs that are no longer in close proximity to the sarcolemmal (SL) membrane and TATS, i.e. outside couplons. Due to the increased distance to LTCCs, these non-coupled RyRs cannot be activated directly by Ca 2þ entry via LTCC but are activated with a delay through Ca 2þ -induced-Ca 2þ -release propagating from coupled sites.
This dys-synchrony reduces the rise time and amplitude of the global Ca 2þ transient 12, [15] [16] [17] and contributes to impaired contractile function.
The architecture of TATS results in different signalling microdomains around coupled and non-coupled RyRs. In healthy pig myocytes, coupled RyRs have a unique NOX2-and CaMKII-dependent regulation during increased heart rate and b-adrenergic stimulation. 18, 19 However, the link between TATS remodelling in disease and the modulation of the larger population of non-coupled RyRs is not well studied.
To date, changes in RyR function in human HF have been exclusively studied at the myocyte level, 7, 20 without information on subpopulations of RyRs, and mostly using HF myocytes only. Comparisons between non-HF and HF are scarce. 10 Recent work studied RyRs extracted from left ventricular (LV) tissues samples from HF and non-HF and reconstituted in bilayers. 21 In the pig with MI, we reported that TATS remodelling affected properties of the RyR subpopulations but did not investigate the signalling mechanisms involved. 22 In a dog model of HF, Belevych et al. 23 found that RyR subpopulations had different characteristics.
However, little is known of the intrinsic properties, modulation, and arrhythmogenic contributions of coupled vs. non-coupled RyRs in post-MI remodelling or in human HF. Yet, selective targeting of modulators controlling RyR P o has become of interest in the treatment of cardiac disease where impaired Ca 2þ handling plays a role. [24] [25] [26] Pilot data from our earlier work indicated that after MI, increased spontaneous RyR activity was exclusively a feature of non-coupled sites.
However, no mechanistic explanation could be offered at the time. 19 This study was designed: (i) to explore and validate the relevance of differences in coupled and non-coupled RyR properties in human HF; (ii) to study underlying mechanisms of the modulation of RyR subpopulations and the arrhythmogenic consequences in post-MI remodelling. Unlike in earlier work, here we induced MI in the anterior wall, 27 which has a larger impact on LV remodelling than MI in the posterior wall.
15,22
Methods
Permission for the use of tissue from human hearts in the heart transplantation programme, explants, and non-used donor hearts, was obtained from the Ethical Committee of the University Hospital (UZ Leuven) with permit number S58824. The study conforms to the Helsinki declaration. Patients received usual care HF medication and data can be found in Supplementary material online, Tables S1 and S2 . Animals were housed and treated according to the Guide for the Care and Use of Laboratory Animals (National Institute of Health, USA), the European Directive 2010/63/EU and experimental protocols were approved by the in-house ethical committee (Ethische Commissie Dierproeven, KU Leuven), with permit numbers P10139, P14176, and P16110.
Cell isolation, confocal microscopy, and electrophysiological recordings were performed as previously described. 19 Single LV myocytes were enzymatically isolated from explanted human hearts 28 (failing, HF, and non-failing, non-HF) and from pigs with MI in the anteroseptal region, with reduced LV function and cellular remodelling 19, 27 (see Supplementary material online, Figures S1 and S2) . In human hearts, myocytes were obtained from the territory of the left anterior descendens coronary artery (LAD), cannulating a diagonal side-branch. If the LAD was not accessible, the left circumflex branch was used. In MI pigs, myocytes from the peri-infarct regions were prepared by cannulating a LAD side-branch and the same region was selected in SHAM animals. We used low (0.5 Hz) and high (2 Hz) frequency stimulation in the whole-cell voltage-clamp mode (-70 to þ10 mV); the Ca 2þ indicator fluo-4 was included in the pipette solution. Ca 2þ sparks were recorded for 15 s after stimulation during confocal line-scan imaging. Cells were scanned along the longitudinal axis, orthogonal to the Z lines, avoiding scanning through nuclei. All experiments were performed at 37 C. Ca 2þ sparks were assigned to coupled/non-coupled release sites based on an established algorithm. 19 A per-pixel spark frequency was calculated and normalized to give a measure in sparks/100 lm/s. Spark frequency was normalized to the length of the line in coupled/non-coupled sites. Ca 2þ waves were induced at 2 Hz stimulation in the presence of isoproterenol (ISO; 10 nM). Ca 2þ wave incidence was normalized to number of waves/ 100 mm/s and wave origins (pixel-based) were used to assign waves to coupled/non-coupled sites.
Immunofluorescent imaging was performed in fixed isolated cells or tissue sections. NCX was used as a surrogate marker to report on TATS membranes and distance masks were constructed as previously described. 19 From these masks, the fraction of coupled/non-coupled RyRs was calculated and co-localization of coupled/non-coupled RyRs with CaMKII was quantified according to the Manders' coefficient. To study TATS in relation to subcellular Ca 2þ release, non-fixed myocytes were stained with wheat-germ-agglutinin-Alexa594 as described previously. Excitation and emission filters were selected using filter wheels (Sutter) and wavelengths discriminated using a triple band pass dichroic filter.
Images were collected at a frequency of a ratio pair every 20 s. ; N humans = 6) (*P-value < 0.05; **P-value < 0.01; ***P-value < 0.001).
Statistics

Results
Myocyte hypertrophy and increased fraction of non-coupled release sites in human HF
HF myocytes were longer than non-HF, without difference in cell width ( Figure 1A ). The density of TATS was significantly lower in HF myocytes and axial tubules were more abundant ( Figure 1A ).
To identify RyR subpopulations in human myocytes, we used a previously described algorithm, 19 establishing criteria as shown in the Supplementary material online, Figure S3A . These pre-established criteria allow studying of coupled and non-coupled release sites in a more rigorous way than used previously, 22, 23 excluding intermediate release sites
(between > 0.5 and < 2 mm) (see Supplementary material online, Figure  S4 ). This approach still includes on average 80% of all release sites in all groups. As shown by its rightward shift, the distribution of the time to half-maximum of the Ca 2þ transient (T F50 ) for all release sites was significantly increased in HF myocytes ( Figure 1B , middle). Quantification of early (coupled) and late (non-coupled) sites confirmed the decrease in the number of coupled sites and the increase of non-coupled sites in HF ( Figure 1B , right). These data indicate that in human HF, hypertrophy is associated with an altered TAT network and an increased proportion of non-coupled release sites.
Increased activity of non-coupled release sites in HF, dependent on CaMKII
In non-HF myocytes, high-frequency stimulation caused a three-fold increase in spark frequency in coupled sites compared with that observed under low-frequency stimulation, whereas the spark frequency was only increased by 1.5-fold in non-coupled release sites ( Figure 1C , middle). In HF myocytes, this frequency-dependent response was absent at coupled sites ( Figure 1C , right), despite a substantial increase in SR Ca 2þ load at 2 Hz in both HF and non-HF ( Figure 2B ); in HF SR Ca 2þ content tended to be lower. In contrast, frequency of sparks at non-coupled sites in HF myocytes was significantly increased at 2 Hz ( Figure 1C , right). The specific CaMKII inhibitor autocamtide-2-related-inhibitory-peptide (AIP) significantly reduced this hyperactivity in non-coupled regions without affecting spark frequency at coupled sites ( Figure 2A ).
Slower and smaller global Ca 2þ transients in HF with beneficial effect of CaMKII inhibition
A reduced synchrony of Ca 2þ release has previously been shown to lead to a slow rise of the Ca 2þ transient in human HF myocytes. 17 Here we confirm that an increased fraction of non-coupled sites in HF myocytes in comparison to non-HF leads to a slower upstroke and reduced amplitude of the Ca 2þ transient ( Figure 2B ). This dys-synchrony is further illustrated by the delay in the fraction of the line-scan that reached half-maximal Ca 2þ release in HF myocytes compared with non-HF. Interestingly, inhibition of CaMKII that reduces diastolic release, removes the differences between HF and non-HF for amplitude and rate of upstroke ( Figure 2C ).
Specific modulation of coupled sites is lost after MI, whereas a de novo regulation appears at non-coupled release sites
Having established remodelling of TATS and spark properties in human HF, we used the post-MI pig model to gain further mechanistic understanding. The pig shares many features of cardiac physiology with humans, and ischaemic cardiomyopathy is the major cause of human HF. The relevance of the pig MI model is further underscored by earlier pilot data indicating that coupled and non-coupled release sites have properties similar to those seen here in human HF and CaMKII dependence was similar to human HF. 19 In MI myocytes in the present study, likewise the CaMKII inhibitor AIP did not affect the spark frequency in coupled sites ( Figure 3A) , but reduced the spark frequency in non-coupled release sites ( Figure 3B , see Supplementary material online, Figure S5A for baseline data). Global Ca 2þ transients in MI myocytes were smaller with reduced rate of upstroke, as in HF, and consistent with the loss of TATS and reduced synchrony of Ca 2þ release (see Supplementary material online, Figure S5B ).
We further examined signalling and microdomains in the RyR subpopulations focussing on ROS as a candidate for post-MI signalling. NOX2 signalling is known to change in cardiac disease 29 and could be affected because of the TATS remodelling, while changes in metabolism and mitochondrial function 27 could affect mito-ROS production. In contrast to SHAM myocytes, inhibition of NOX2 with gp91 ds-tat peptide, did not affect the spark frequency in coupled sites after MI ( Figure 3A) . Since noncoupled sites lack TATS, NOX2-generated ROS at the TAT membrane is unlikely to affect non-coupled RyRs as confirmed by the lack of an effect of gp91 application (see Supplementary material online, Figure S6 ). Using the global ROS scavenger, NAC, we probed for ROS-mediated modulation from other sources. NAC significantly reduced the spark frequency in non-coupled sites ( Figure 3B ). None of these interventions affected the SR Ca 2þ load (see Supplementary material online, Figure S7B and C).
CaMKII and NOX2 localization is intact after MI
The lack of frequency-response in coupled release sites after MI could be attributed to the specific loss of CaMKII and/or NOX2 in coupled regions. In both SHAM and MI myocytes, there was however a similar degree of co-localization between CaMKII and coupled or non-coupled RyRs (Figure 4Aa ). No change in CaMKII expression in SHAM and MI tissue was detected (see Supplementary material online, Figure S8 ). The localization of NOX2 at the TATS was intact after MI ( Figure 4Ab , see Supplementary material online, Figure S9A and B). Figure 4B ). In addition, the amplitude and rate of upstroke of Ca 2þ transients in regions of coupled sites were reduced (see Supplementary material online, Figure S5C ). We tested the hypothesis that changes in NOS1 could reduce ROS in the dyadic cleft, as e.g. produced by local NOX2 ( Figure 4C) . Recently, local ROS scavenging mechanism at the SR have been described, whereby NOS1-derived NO can scavenge xanthine oxidase (XO)-produced ROS. 30 During disease, NOS1 has been shown to translocate from the SR to the TATS. 31 Translocated NOS1-derived NO at the TATS could thus mask a local ROS microdomain by scavenging ROS produced by NOX2 in MI myocytes. Inhibition of NOS1 with L-NAME, and with the more specific L-VNIO produced a significant increase in the spark frequency in coupled sites in MI myocytes to a similar level as in control. NOS inhibition did not affect the frequency-response in coupled sites in SHAM myocytes ( Figure 4C ).
ROS from mitochondria modulate noncoupled RyRs after MI
The data in Figure 3B imply that there must be an alternative ROS source to NOX2 affecting the non-coupled sites in MI. We hypothesised that the mitochondria were responsible. Scavenging mitochondrial ROS (mito-ROS) using mitoTEMPO significantly reduced spark frequency at non-coupled regions in MI, without affecting coupled sites ( Figure 5A) ; there was no effect in SHAM. SR Ca 2þ content was unchanged by this manoeuver in SHAM or MI (see Supplementary material online, Figure S7B and C). Inhibition of XO with oxypurinol had no effect on sparks in either SHAM or MI myocytes (see Supplementary material online, Figure S10 ) indicating that this enzyme did not contribute to ROS generation. These observations raised the question whether pacing at 2 Hz selectively induced mito-ROS in MI but not in SHAM. To test this possibility, we studied cellular redox potential through measuring the FAD/NAD(P)H ratio. During stimulation at 2 Hz, the NAD(P)H signal 
After MI, Ca 2þ waves are more frequent and originate in non-coupled release sites
Increased RyR activity/sensitivity may result in spontaneous Ca 2þ waves that promote arrhythmias. We investigated the susceptibility for Ca 2þ waves in MI during b-adrenergic stimulation at 2 Hz, mimicking the in vivo adrenergic effects. MI myocytes exhibited more Ca 2þ waves than SHAM, and these Ca 2þ waves generated significantly larger NCX currents (I NCX ) ( Figure   6B ). This was reflected by an increased number and amplitude of delayed-afterdepolarizations (DADs) as well as an increase in number of spontaneous action potentials (APs) ( Figure 6C) . We related the source of Ca 2þ waves to either coupled and non-coupled sites based on the waves originated more frequently from non-coupled sites ( Figure 6D ). To induce triggered activity, and ultimately arrhythmias, membrane depolarization by the inward I NCX generated by the Ca 2þ waves must reach the threshold for AP generation. Larger I NCX is generated when multiple Ca 2þ waves collide. In MI, more cells exhibited colliding Ca 2þ waves compared with SHAM ( Figure 6Ea ). These colliding waves had a larger amplitude and I NCX compared with single Ca 2þ waves in MI myocytes (see Supplementary material online, Figure S11 ). Colliding waves originating from non-coupled sites had the highest peak and integrated I NCX (Figure 6Eb ).
Inhibition of CaMKII and mito-ROS reduces Ca 2þ waves from non-coupled sites in MI
In MI myocytes, mitoTEMPO and AIP reduced the increased wave frequency originating from non-coupled sites without significantly affecting those arising from coupled regions ( Figure 7A ). Direct inhibition of RyR opening with flecainide or S107 reduced Ca 2þ waves in both MI and SHAM.
We assessed the impact of these interventions on excitationcontraction coupling and the Ca 2þ transient. Flecainide, CaMKII and mitoTEMPO did not affect the Ca 2þ transient amplitude, whereas S107
significantly reduced the amplitude in both SHAM and MI myocytes ( Figure 7B ).
Discussion
TATS remodelling in ventricular myocytes after MI and in HF, leads to an increase in non-coupled release sites. Unlike in the healthy heart, these For each cell, the FAD/NAD(P)H ratio measured after pacing at 2 Hz was normalized to the rest value. The graph represents the frequency distribution with the fitted Gaussian curves in SHAM and MI (*P-value < 0.05; ***P-value < 0.001).
RyR microdomains in post-MI remodelling and human HF sites, outside of couplons, exhibit increased spontaneous activity during diastole at higher heart rates. This arises through distinct alterations in Ca 2þ and ROS microdomains around the different RyR populations.
After MI, non-coupled release sites are at the origin of Ca 2þ waves.
These Ca 2þ waves generate larger depolarizing currents by simultaneously activating multiple Ca 2þ release sites, thereby highlighting the arrhythmogenic potential of these sites.
TATS remodelling in human HF impacts on RyR activity and global Ca 2þ transient properties
We observed a significant reduction in TATS density, predominantly of the T-tubules (TTs) in HF, extending earlier studies in human tissue. Early electron microscopy studies described dilated TTs. 32 Other features previously described include an irregular distribution, 11, 17 an increase in TT diameter 11 and a reduction in TT density. [33] [34] [35] TATS remodelling results in an increased fraction of non-coupled RyR cluster sites, in line with data from a canine model of HF 36 and human HF myocytes. 35 This remodelling is associated with loss of synchrony and reduced amplitude of the Ca 2þ transient through delayed opening of the non-coupled RyRs. Similar findings were reported in animal models 12,13,15 but data from human HF are scarce or did not include information from non-HF myocytes. 17, 35 This study also adds new information regarding the intrinsic properties of RyRs clusters at coupled and non-coupled sites. Indeed, previous studies have only reported on overall RyR activity recorded as sparks in diastole and in lipid bilayer experiments, without distinguishing subpopulations. 7, 21, 37 They mostly report an increase in total spark frequency, although Lindner et al. 10 reported a decrease in HF. An important difference between the aforementioned study and ours is that we studied cells under voltage-clamp. The voltage-clamp mode with controlled membrane potential and equal duration of membrane depolarization achieves a more equal SR load and Ca 2þ fluxes allowing better dissection of RyR properties with less influence of confounding factors (including disease associated remodelling of the AP and resting membrane potential). Our finding that the spark activity in non-coupled sites is sensitive to CaMKII inhibition is in line with previous reports on RyR properties in HF, although a comparison to non-HF was not included in those studies. 7, 37 Recently, lipid bilayer experiments on RyR activity support these findings, with a major role for RyR phosphorylation and thiol oxidation in HF conditions. 21 In line with the study from Fischer et al., 7 no differences in response to CaMKII inhibition were found between myocytes from ischaemic and dilated cardiomyopathy (see Supplementary material online, Figure S12 ). The data complement earlier work on the global assessment of Ca 2þ transients in HF vs. non-HF human myocytes. 38 Our data further show that in HF, CaMKII inhibition can reduce diastolic events with favourable effects on the global Ca 2þ transient. activity. This could explain the loss of CaMKII activation in coupled regions after MI, in line with the increased spark frequency with NOS inhibition. NO production may mask the ROS microdomain through translocation of NOS1 from the SR to the TATS. This may be through ROS in the dyadic cleft or ROS from mitochondrial sources.
Another possible mechanism may be through dysregulation of localized antioxidant mechanisms. Glyceraldehyde 3-phosphate dehydrogenase, located at the TATS, 46 potentially regulates the redox state at SR-SL junctions by the production of NADH. In support of this notion, ischaemic and dilated cardiomyopathies are known to cause a shift in metabolic substrate utilization from free fatty acids to glucose, 27, 47 thereby increasing the rate of glycolysis and associated NADH production, resulting in ROS scavenging at the dyadic cleft.
Non-coupled release sites have increased spontaneous activity
Our data show a de novo form of modulation of non-coupled sites, dependent on CaMKII activation and mito-ROS. Increased CaMKII activity in the regulation of RyRs has been associated with several cardiac diseases 7,37,48,49 but its selective activation at non-coupled regions was so far not reported. The low rate of upstroke of triggered Ca 2þ release in non-coupled regions makes it unlikely that CaMKII is activated by Ca 2þ in non-coupled regions. Instead, our data suggest a more prominent role for mito-ROS, rather than Ca 2þ , in the activation of CaMKII, as recently shown in diabetic mouse heart. 50 Moreover, increased levels of mito-ROS manifest in patients 51 and animals with advanced HF.
52-54
The increased activity of RyRs at non-coupled sites in MI occurs without apparent change in SR Ca 2þ content. We could not yet study the full relationship between SR leak and content. 55 It is conceivable that our experiments occur at the exponential part of this relationship together with a shift in the curve due to RyR post-translational modifications. Therefore, one can have increased leak with small or no changes in SR Ca 2þ content. The role of CaMKII in arrhythmias has been previously investigated, 57 including ROS-induced CaMKII activation. 58, 59 Here we show that CaMKII inhibition in MI selectively reduced waves originating from non-coupled RyRs without adverse effects on coupled RyRs and excitation-contraction coupling. CaMKII inhibition or mito-ROS scavenging would thus be better strategies than direct RyR inhibition, which is less discriminating. Last, the impact of waves on depolarizing currents was larger in MI. This may at first glance be counterintuitive as non-coupled sites are more distant from the membrane. However, this distance may also cause a temporary increased re-circulation of Ca 2þ in the stores with eventually larger cell-wide Ca 2þ release, colliding waves, larger I NCX , and ultimately, triggered activity. In a pilot study, in vivo monophasic AP from the peri-infarct region during 2 Hz pacing and isoproterenol support the occurrence of high amplitude DADs (see Supplementary material online, Figure S13 ), whereas only low amplitude DADs were observed in SHAM animals. In three out of five MI pigs, this pro-arrhythmic pacing protocol triggered premature ventricular complexes in vivo. This was rarely observed in SHAM animals.
Non
Limitations and future directions
Human samples are limited in nature and quantity and not available for all experiments. Nevertheless, our key observations in pig suggest comparable mechanisms after disease remodelling in human HF myocytes. In this study, only indirect and global ROS measurements were used although development of local ROS measurements could provide further insights. For local [Ca 2þ ], targeted probes are available but cell culture [60] [61] [62] complicates the application as culture affects TT ultrastructure.
Our biochemical characterization of RyR and CaMKII modifications remains limited. No differences were found for the direct oxidation of RyR between SHAM and MI tissues (see Supplementary material online, Figure S14A ). Immunostainings for both phosphorylation and oxidation of CaMKII showed a significant increase in MI myocytes (see Supplementary material online, Figure S14B and C). These approaches are however not sufficient to detect dynamic changes during live cell experiments at the subcellular level. In the current experiments, we have relied on pharmacological tools and despite the use of different agents and controls, there is always the potential for non-selective or indirect effects. This limitation was preferred over gene manipulation that requires cell culture, introducing other potential confounders.
In this work, a fraction of nearly 20% of non-coupled RyRs was observed in SHAM pig myocytes using functional and immunostaining methods (see Supplementary material online, Figure S1 ). This is high compared with studies in human tissues, including present data, and dog myocytes. 35, 63 Species-specific and methodological differences might account for some of this apparent disparity. Here and in our previous work, 19 we predominantly rely on the relationship between SR Ca 2þ release and TATS distance to identify RyR subgroups. If not all RyRs are active this may introduce discrepancies.
Conclusion
In HF and after MI, RyR microdomain organization enhances spontaneous Ca 2þ release and sparks from non-coupled sites, in a manner that is dependent on CaMKII activation and mito-ROS production. This specific modulation may generate a substrate for arrhythmia that appears to be responsive to selective pharmacologic modulation.
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